Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy.
Kenji MorimotoTadaaki YamadaTakayuki TakedaShinsuke ShiotsuKoji DateTaishi HaradaNobuyo TamiyaYusuke ChiharaYoshizumi TakemuraTakahiro YamadaHibiki KandaMasaki IshidaAkihiro YoshimuraMasahiro IwasakuShinsaku TokudaYoung Hak KimKoichi TakayamaPublished in: Drugs & aging (2023)
G8 score evaluation before treatment initiation was useful as a prognostic factor for ES-SCLC patients who received PD-L1 inhibitors and platinum-etoposide chemotherapy, even with good PS.